Abbreviations used: CDG, congenital disorder of glycosylation; OTase, oligosaccharyltransferase.
Introduction
Protein N-glycosylation is a common and essential co-and post-translocational modification of membrane and secreted proteins that in eukaryotes is catalysed by the multiprotein complex enzyme oligosaccharyltransferase (OTase) 1 . The oligosaccharide Glc 3 Man 9 GlcNAc 2 is assembled on the lipid carrier dolicholpyrophosphate and transferred en bloc by OTase 3 onto selected asparagines, primarily in N-glycosylation sequons (NX(S/T); X≠P) as nascent polypeptide is translocated into the endoplasmic reticulum (ER) 1, 2 . Further extension and modification of the glycan structures on mature proteins occurs in the Golgi [3] [4] [5] . N-glycans assist protein folding in the ER, and the specific glycan structures on mature glycoproteins modulate protein function in developmental programs, during immune responses, in cell-cell interactions and in many other cellular processes [6] [7] [8] .
A number of the genes that encode for enzymes in the N-glycosylation pathway have been shown to be involved in human health and disease 6, 9 . Many studies have revealed that alterations in glycan expression are associated as causative or incidental factors in relatively rare Congenital Disorders of Glycosylation (CDG), widespread acquired diseases and cancer 6, 7, [9] [10] [11] . CDGs are conceptually divided into CDG-I, where the genetic defect is in the ER in the N-glycosylation pathway before addition of glycan to protein, and CDG-II, where the defect is in the Golgi. Thus, CDG-I results in inefficient glycosylation of asparagines, while CDG-II results in changes to the glycan structures on mature glycoproteins 6 .
Underglycosylation is the underlying cause of disease in CDG-I, resulting in an increase in misfolded glycoproteins and alterations in their functions through reduced glycosylation of particular asparagines. However, with over half of all proteins predicted to be glycosylated, the sequence and structural diversity of protein acceptor sites is extraordinarily large 12 . It is currently not clear which particular subset of asparagines are underglycosylated in CDG-I.
However, a study using targeted SRM-MS showed that transferrin isolated from the blood of CDG-I patients had lower glycosylation occupancy specifically at its second N-glycosylation site 13 . Additionally, several familial mutations in the homologous OTase subunits MagT1 and Tusc3 have been linked to a form of CDG-I leading to non-syndromic mental retardation [14] [15] [16] .
4
Studies using a manipulable yeast genetic system showed that the yeast homologues of these proteins are required for efficient site-specific N-glycosylation of selected asparagines 17, 18 . Other CDGs have also been extensively studied in yeast. Saccharomyces cerevisiae alg mutants (alg, asparagine-linked glycosylation) are defective in the biosynthesis of the dolichol-linked Glc 3 Man 9 GlcNAc 2 , 19, 20 and the mutations in the human alg homologs causing different types of CDG can be functionally studied by heterologous expression in yeast 6 . The ALG3 gene is highly conserved in eukaryotes, and its mutation also results in a similar phenotype in Arabidobsis thalina 21, 22 . Knock-out mutants of these ALG genes in S.
cerevisiae are generally viable, and have also been used to characterize the pathway of Nglycosylation in the ER 19 .
Glycosylation occupancy can be measured semi-quantitatively on many proteins using MSbased methods 17, 18, [23] [24] [25] . Traditionally in these approaches in yeast, Endo H is used as a deglycosylation agent followed by protease treatment and MS analysis to identify glycosylated and non-glycosylated peptides. Enrichment of glycoproteins rather than glycopeptides allows detection of both glycosylated and non-glycosylated versions of the same peptide. This allows direct relative quantification of site-specific glycosylation occupancy, although entails some reduction in the enrichment efficiency obtainable through glycopeptide enrichment 25 . Endo H cleaves all N-glycans of wild type yeast, which are all high-mannose structures, and conveniently leaves previously glycosylated asparagines tagged with a single N- 
Experimental procedures

Yeast Strains
Yeast strains used were BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and the Δalg3 mutant derivative thereof (Open Biosystems). Cells were grown to mid log phase at 30˚C in YPD (2% Bacto peptone, 1% yeast extract, and 2% glucose).
Cell Wall Protein Sample Preparation
Triplicates of 50 ml of cells grown to mid log phase were harvested and lysed with agitation for 1 hr at 4˚C using glass beads (Sigma) in 50 mM Tris HCl, pH 7.5, 1 mM PMSF and 1 x
Complete protease inhibitor cocktail (Roche). Based on previously reported methods 17, 27 , covalently linked cell wall material was pelleted by centrifugation at 18000 rcf for 1 min and washed 4 times with ice-cold 50 mM Tris-HCl pH 7.5. The pellet was resuspended in 50 mM
Tris-HCl pH 8.0, 2 % SDS, 7 M Urea and 2 M Thiourea. Cysteines were reduced and alkylated by addition of dithiothretiol to 10 mM and incubation at 30˚C with agitation for 30 min, followed by addition of acrylamide to 50mM and further incubation with agitation at 30˚C for 1 hr. Non-covalently linked proteins were removed by washing the 18000 rcf pellet five times with 1 ml 50mM Tris-HCl, pH 8, 2 % SDS, 7 M urea and 2 M thiourea, followed by five washes with 2 % SDS. The pellet was resuspended in 100 µl 1% NP40 and 1x G7 buffer (New England Biolabs) and aliquoted into 50 µl followed by addition of 500 units of PNGase F (New England Biolabs) and incubated at 37˚C with agitation for 16 h. The negative control 6 was incubated in the same buffer without PNGase F enzyme. The cell wall proteins were pelleted at 18000 rcf and washed 5 times in 50 mM Tris-HCl pH 8.0. The final cell wall pellet, equivalent to 12.5 ml of cell culture, was resuspended in 50 mM NH 4 HCO 3 , and proteins were digested with either trypsin 4 µg/ml (Sigma) or AspN 1 µg/ml (Promega) at 37˚C for 16 h with agitation.
Mass Spectrometry and data analysis
Peptides were desalted using C18 ZipTips (Millipore) and analysed by LC-ESI-MS/MS using a Prominence nanoLC system (Shimadzu) and TripleTof 5600 mass spectrometer with a Nanospray III interface (AB SCIEX). Approximately 2 µg peptides were desalted on an Agilent Peptides identified with greater than 99 % confidence and with a local false discovery rate of less than 1 % were included for further analysis, and MS/MS fragmentation spectra were manually inspected. Extracted ion chromatograms were obtained using PeakView 1.1.
Relative quantification of site-specific glycosylation occupancy was determined for each deamidated (deglycosylated) / unmodified (non-glycosylated) tryptic peptide pair without considering variable response factors of the unmodified and deamidated peptides.
Occupancy was defined as the ratio of the extracted ion intensities of the deamidated peptide ion to the sum of the intensities of the deamidated and unmodified peptide ions 17 .
Results
Identification and relative quantification of N-glycosylation site occupancy in cell wall proteins from wild type and Δalg3 yeast cells using PNGase F treatment followed by trypsin digestion.
We asked whether glycosylation occupancy in the yeast Δalg3 strain showed site-specific alterations. To efficiently detect multiple glycosylation sites, enrichment of glycoproteins is Fig. 1 A and C). We found 10 Nglycosylation sites that showed decreased levels of glycosylation occupancy in Δalg3 compared to wild type. Ecm33p_328 showed the most severe decrease in glycosylation occupancy at 37 % (Table 2 and Fig. 1 A-D) . Some glycosylation sites showed only mild under-glycosylation, such as Crh1p_177 that showed 96 % occupancy in the Δalg3 mutant (Table 2) . We found six sites that were completely (100 %) glycosylated in both Δalg3 and wild type cells, and three sites were found to be completely non-glycosylated in both wild type and mutant yeast cells (Table 2) . Two glycosylation sites were mildly under-glycosylated in wild type cells, Ecm33p_328 (Table 2 and Fig. 1 A and B) and Pry3p_101, and were both found to be further under-glycosylated in the Δalg3 strain (Table 2 ). In summary, we found 16 glycosylation sites that were occupied in wild type cells, 10 of which were under-glycosylated in the Δalg3 strain.
Spontaneous deamidation of NG sequences has been reported to occur during standard proteomic sample preparation [30] [31] [32] . It was therefore important to confirm that the deamidation events we detected were due to PNGase F catalysed glycan release, rather than spontaneous chemical deamidation of non-glycosylated asparagines. Two of the detected glycosylation sites, Crh2p_310 and Gas1p_40, have sequons with the sequence NGS/T (Table 1) , and would therefore be prone to spontaneous deamidation. We did not detect any deamidated peptide corresponding to Crh2p_310 in negative control samples not deglycosylated with PNGase F. In the negative control of Δalg3 cells we did detect a weak MS peak corresponding to ions of deamidated Gas1p_40 peptide, indicating that some portion of the unglycosylated form of this peptide underwent spontaneous deamidation during sample preparation (data not shown). However, no such peak was detected in the wild type negative control, indicating that this site is completely glycosylated in wild type, and is partially under-glycosylated in Δalg3 cells. The intensity of the deamidated Gas1p_40 peptide in the negative control was very low and was neglected in calculation of relative glycosylation occupancy at this site, leading to a slight underestimation of the level of under-glycosylation at Gas1p_40 in the Δalg3 strain (Table 2) . No detectable spontaneous deamidation of asparagines in other sequons were detected in any of the negative controls.
Identification of N-Glycosylation sites in yeast cell wall proteins with PNGase F treatment followed by AspN digestion.
Deglycosylation with PNGase F and digestion with trypsin allowed detection and relative quantification of site occupancy in Δalg3 cells. However, the mass shift upon deamidation is ~1Da, which in some cases can be difficult to differentiate from the normal isotopic distribution of non-deamidated peptides in the case that the deamidated and non-deamidated versions of that peptide are not separated by C18 LC prior to MS detection. This is in contrast to the ready differentiation of previously glycosylated asparagines tagged with a Δmass of 203.08
Da in the case of Endo H glycan release. This ambiguity has the potential to make measurement of site-specific N-glycan occupancy difficult. To overcome these difficulties and to further identify specific N-glycosylation sites showing under-glycosylation in Δalg3 yeast cells, we therefore treated the cell-wall glycoproteins with PNGase F followed by digestion with the protease AspN and detection with LC-ESI-MS/MS. Deamidation of a previously glycosylated asparagine converts the amino acid to an aspartic acid that will be recognized as a cleavage site for AspN. Consequently AspN will cleave at deamidated asparagines that were glycosylated prior to treatment with PNGase F. This will allow clear differentiation of previously glycosylated asparagines, in contrast to the difficulties of PNGase F/trypsin as described above. Using this approach we identified 49 peptides (> 99 % confidence) that had been cleaved at a deamidated asparagine in a sequon (glycosylated) or contained an unmodified sequon (non-glycosylated) ( Table 3 , Supporting Information). The 49 peptides represented 42 NX(S/T) sequons in 14 different proteins ( Table 3) . 37 of these sequons were identified as glycosylated. We found seven sequons that were present in unmodified peptides (Table 3) . Three of these unmodified sequons (Ecm33p_328, Gas3p_350 and Crh2p_96)
were only found in Δalg3 samples and were also detected as peptides cleaved at the corresponding deamidated asparagine in both wild type and Δalg3 cells, indicating partial glycosylation at these three sites in the Δalg3 mutant. Four sequons were identified exclusively as non-glycosylated. Two of these (Ecm33p_209 and Crh1p_177) were only detected from Δalg3 cells, indicating that these sites are under-glycosylated in the Δalg3 mutant strain (Table 3) . Crh1p_177 was also identified in tryptic peptides both as a (deamidated) glycopeptide and a non-modified peptide (Table 1) , showing some underglycosylation at this site (Table 2 ). In total we identified five glycosylation sites that were under-glycosylated in the Δalg3 mutant strain using PNGase F followed by AspN treatment. In addition, we identified two sequons in non-modified peptides, Ccw14p_87 and Tos1p_417, present in both wild type and Δalg3 positive and negative controls (no PNGase F treatment), suggesting that these two sequons are not glycosylated in wild type or the Δalg3 mutant strain (Table 3 ). AspN cleavage due to spontaneous deamidation of an asparagine in an NGS sequon was detected at minor levels at Gas1p_40 in the Δalg3 negative control, indicating that a portion of this site that was not glycosylated in these cells underwent spontaneous chemical deamidation. Relative quantification of glycosylation site occupancy was not performed using AspN peptides due to the inability to directly compare the deamidated and unmodified forms of the same peptide.
Characteristics of sequons that showed decreased glycosylation occupancy in Δalg3 cells.
N-Glycosylation is a general co-translational modification affecting many glycosylation sites on many different proteins within the cell. Only ~ 70 % of NX(S/T) sequons are glycosylated in proteins that are translocated into the ER 17, 18, 23, 24 . However, the sequons that were normally glycosylated in wild type cells were not evenly affected in the Δalg3 mutant strainsome sites remained efficiently glycosylated while others showed severe under-glycosylation.
We compared the characteristics of glycosylation sites that were underglycosylated and sites that showed no change in glycosylation occupancy in Δalg3 cells (Table 2 and 4). We found that sequons that were efficiently glycosylated in Δalg3 cells were more likely to be located in loops of folded proteins (not in secondary structural elements) and contain threonine in the +2 position (Fig 2) .
Identification of novel N-glycosylation sites in yeast cell wall proteins.
In S. cerevisae there are 196 N-glycosylation sequons that have been directly experimentally shown to be occupied (UniProt) 17, 33 . The method we describe here used cell wall enriched proteins that contain a limited number of proteins compared to a recently described method using filter-aided-sample-preparation (FASP) from whole cell extracts enriched for glycoproteins with ConA 33 . Nonetheless, using our approach we found in total 54 different occupied glycosylation sites (Table 1 and 3) , 26 of which have not been reported previously (Table 5) , raising the total number of known occupied N-glycosylation sites in S. cerevisae to 222.
Discussion
We developed an LC-MS based analytical method to identify N-glycosylation sites and successfully determined the relative glycosylation occupancy at 19 sites using the yeast Δalg3 strain as a model. Independent of the yeast strain studied, deglycosylation with PNGase F followed by AspN digestion increased the number of glycosylation sites that could be detected in a complex protein sample at one time, when compared with trypsin digest. It appears that proteins with multiple N-glycosylation sites become more accessible to digest with AspN and MS analysis after treatment with PNGase F compared with Endo H. Of the 26 new sites we found in this study, 22 were identified using the combination of PNGase F and AspN. In total we could detect 54 different occupied glycosylation sites. The approach we describe here is therefore complementary to standard techniques, and increases the number of Nglycosylation sites that can be detected at the same time on many different proteins.
While most glycosylation sequons were efficiently glycosylated in wild type cells, the altered glycan structure in the Δalg3 strain reduces the general glycosylation activity of OTase, leading to underglycosylation 26, 29 . However, glycosylation sites were not uniformly affected in
Δalg3 cells, with the subset of sites with lower affinity for OTase most strongly affected. We found 13 specific glycosylation sites that were under-glycosylated in the Δalg3 strain 13 compared to wild type cells (Table 4 ). The features of these glycosylation sites suggest that they are the subset of normally modified sites that are more difficult for OTase to glycosylate.
For instance, these under-glycosylated sites are enriched in serine at the +2 position (Fig 2A) .
NxS sequons are glycosylated ~40 times less efficiently than NxT sequons, 34 because of specific recognition of threonine at the +2 position by the peptide acceptor binding site of OTase 35 . Under-glycosylated sites in the Δalg3 strain were also likely to be present in secondary structural elements (helices or sheets), whereas efficiently glycosylated sites were more likely present in flexible loops (Fig 2B) . Protein folding competes with glycosylation by
OTase because the peptide acceptor binding site of OTase requires a flexible stretch of peptide for tight binding 35 . As secondary structure forms early in protein folding, glycosylation sites in secondary structural elements will have reduced affinity to OTase. The subset of glycosylation sites both present in flexible loops and with threonine at the +2 position were efficiently glycosylated (Fig 2C) , suggesting a combination of these factors influences peptide acceptor binding to OTase, and hence glycosylation efficiency. homologous OTase subunits (Δost3/Δost6) 17 . All six of these sites were shown to be rescued by overexpression of Ost3p, although two sites could be rescued by over-expressing of either Ost3p or Ost6p 17 . Furthermore, one glycosylation site, Gas1p_253, was shown to require
Ost6p for complete glycosylation occupancy 17 . Interestingly, we found that glycosylation occupancy of Gas1p_253 was not affected in Δalg3 cells (Table 2) , which express both 14 Ost3p-and Ost6p-containing OTase isoforms. This emphasizes the importance of the protein substrate specificities of OTase isoforms in defining the characteristics of an efficiently glycosylated asparagine.
Our results may be complicated by the ability of many proteins to fold correctly even without glycosylation at many sites, as long as a certain critical level of glycosylation is present. This will mean that if glycosylation is strictly required at a particular asparagine for correct protein folding, then that asparagine will appear to always be glycosylated, even though most of the nascent polypeptide that is not modified will be degraded by the quality control systems of the ER 2 . In addition, glycosylation efficiency may depend on factors such as local folding of the target protein close to the sequon and the protein substrate specificities of the particular OTase isoforms present 17, 36 . However, in combination this and previous studies have detected almost every sequon in both glycosylated and non-glycosylated forms, suggesting that these effects are relatively minor. Therefore, it is reasonable to imply that sites that are easier to glycosylate would be expected to show full occupancy and sites that are more difficult to glycosylate would be found under-glycosylated.
Conclusion
Mutations in the human ALG3 gene cause a rare form of CDG (CDG-Id) 37 . Reduced OTase activity due to the altered structure of the lipid-linked glycan substrate in this disorder is likely to affect N-glycosylation occupancy in a site-specific manner, similar to the patterns we observe here in a S. cerevisiae model system. We predict that glycosylation sites in NxS sequons and those located in secondary structural elements will be the most likely to show reduced glycosylation in CDG-Id. Many different diseases and health conditions in addition to the CDG spectrum are caused by or associated with defects in glycosylation and consequently decreased levels of N-glycosylation occupancy at many different glycosylation sites in many different proteins. In conjunction with appropriate glycoprotein or glycopeptide enrichment strategies, the method we describe here could potentially be further developed to study human N-glycosylation site occupancy using clinical tissue, serum or saliva protein samples, leading to discovery of new biomarkers for CDG and other disorders and improved diagnostics. Tables   Table 1 . Peptides containing N-glycosylation sequons identified by mass spectrometry.
Proteins covalently linked to the yeast polysaccharide cell wall were prepared, glycans were released by peptide-N-glycosidase F, and proteins were digested with trypsin, detected by LC-ESI-MS/MS, and identified by ProteinPilot. Graphical Abstract
